T cell response in patients with COVID-19
L Liu, L Xu, C Lin - Blood Science, 2020 - mednexus.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the third zoonotic
coronavirus to have an outbreak in the first two decades of the 21st century. Human-to …
coronavirus to have an outbreak in the first two decades of the 21st century. Human-to …
Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
Y Ni, A Alu, H Lei, Y Wang, M Wu, X Wei - Molecular biomedicine, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). COVID-19 can spread to …
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). COVID-19 can spread to …
Dysregulated immune responses in SARS-CoV-2-infected patients: a comprehensive overview
I Kudryavtsev, A Rubinstein, A Golovkin, O Kalinina… - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in
humans more than two years ago and caused an unprecedented socio-economic burden on …
humans more than two years ago and caused an unprecedented socio-economic burden on …
COVID-19: an immunopathological view
K Kadkhoda - MSphere, 2020 - Am Soc Microbiol
Since its emergence in December 2019, it took only a couple of months for an outbreak of
the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World …
the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World …
Possible mechanisms responsible for acute coronary events in COVID-19
The novel coronavirus (SARS-CoV-2) is primarily a respiratory pathogen and its clinical
manifestations are dominated by respiratory symptoms, the most severe of which is acute …
manifestations are dominated by respiratory symptoms, the most severe of which is acute …
Dysregulated innate immune and inflammatory responses in SARS-CoV-2 infection and COVID-19 severity
P Ghosh, S Nagaraja, S Basavaraju… - Critical Reviews™ in …, 2021 - dl.begellhouse.com
Pathogenic coronaviruses (CoVs) have caused human respiratory infections and severe
disease outbreaks in the past two decades. Recent severe acute respiratory syndrome …
disease outbreaks in the past two decades. Recent severe acute respiratory syndrome …
Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia
L Lin, L Lu, W Cao, T Li - Emerging microbes & infections, 2020 - Taylor & Francis
ABSTRACT Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact …
Cytokine storm in COVID-19: the current evidence and treatment strategies
Y Tang, J Liu, D Zhang, Z Xu, J Ji, C Wen - Frontiers in immunology, 2020 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen that causes
coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has …
coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has …
[HTML][HTML] Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
X Li, Y Zhang, L He, J Si, S Qiu, Y He… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Following onset of the first recorded case of Coronavirus disease 2019 (COVID-19) in
December 2019, more than 269 million cases and over 5.3 million deaths have been …
December 2019, more than 269 million cases and over 5.3 million deaths have been …
First glimpses into the mechanisms of Long COVID
A Flemming - Nature Reviews Immunology, 2022 - nature.com
Post-acute sequelae of COVID-19 (PASC), sometimes referred to as 'Long COVID', are
observed in 30–70% of individuals post-SARS-CoV-2 infection. These can include loss of …
observed in 30–70% of individuals post-SARS-CoV-2 infection. These can include loss of …